Roivant Sciences Forecast, price target & analysts
Roivant Sciences Target price 2025 - Analyst rating & recommendation
Roivant Sciences Classifications & Recommendation:
Roivant Sciences Price Target
| Target Price | $18.36 |
| Price | $11.39 |
| Potential |
61.19%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Roivant Sciences 2026 .
The average Roivant Sciences target price is $18.36.
This is
61.19%
register free of charge
$42.00
268.74%
register free of charge
$12.12
6.41%
register free of charge
|
|
| A rating was issued by 16 analysts: 14 Analysts recommend Roivant Sciences to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Roivant Sciences stock has an average upside potential 2026 of
61.19%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 29.05 | 29.82 |
| 11.19% | 2.65% | |
| EBITDA Margin | -3,785.23% | -4,297.74% |
| 54.21% | 13.54% | |
| Net Margin | -592.01% | -3,058.81% |
| 104.45% | 416.68% |
10 Analysts have issued a sales forecast Roivant Sciences 2026 . The average Roivant Sciences sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Roivant Sciences EBITDA forecast 2026. The average Roivant Sciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Roivant Sciences Analysts have issued a net profit forecast 2026. The average Roivant Sciences net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Mar '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.23 | -1.31 |
| 104.40% | 469.57% | |
| P/E | negative | |
| EV/Sales | 95.77 |
10 Analysts have issued a Roivant Sciences forecast for earnings per share. The average Roivant Sciences EPS is
This results in the following potential growth metrics and future valuations:
Roivant Sciences...
Current Roivant Sciences Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 18 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 19 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 19 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 18 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 13 2024 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 19 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 19 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
